Thomas Malley, Director at OvaScience, Inc. (OVAS), bought 35,000 shares at $50.00 ($1.8M) on 2015-01-13, disclosed to the SEC on 2015-01-15.
Open-market purchase of $1.8M OVAS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BGNE | BUY | 2016-11-28 | $960K | — | Filing → |
| KURA | BUY | 2015-12-17 | $400K | — | Filing → |
| OVAS | BUY | 2015-04-09 | $143K | — | Filing → |